A process prepares dialkyl 1,4-cyclohexanedicarboxylates by ring hydrogenation of the corresponding dialkyl terephthalate having a CO value of less than 0.3 mg KOH/g. The dialkyl 1,4-cyclohexanedicarboxylates thus produced can be used as plasticizers or as a component of a plasticizer composition for plastics, in particular PVC.

Cis and trans ruthenium complexes that can be used as catalysts for ring opening metathesis polymerization (ROMP) are described. The complexes are generally square pyramidal in nature, having two anionic ligands X. Corresponding cationic complexes where one or both of the anionic ligands X are replaced by a non-co-ordinating anionic ligand are also described. Polymers such as polydicyclopentadiene (PDCPD) can be prepared using the catalysts.

Cis and trans ruthenium complexes that can be used as catalysts for ring opening metathesis polymerization (ROMP) are described. The complexes are generally square pyramidal in nature, having two anionic ligands X. Corresponding cationic complexes where one or both of the anionic ligands X are replaced by a non-co-ordinating anionic ligand are also described. Polymers such as polydicyclopentadiene (PDCPD) can be prepared using the catalysts.

A compound having a group represented by formula (Ia): ##STR00001##
wherein R.sup.1 and R.sup.2 each independently represent a C.sub.1 to C.sub.8 fluorinated alkyl group, ring W represents a C.sub.5 to C.sub.18 alicyclic hydrocarbon group that may have a substituent, and * represents a binding site.

A compound having a group represented by formula (Ia): ##STR00001##
wherein R.sup.1 and R.sup.2 each independently represent a C.sub.1 to C.sub.8 fluorinated alkyl group, ring W represents a C.sub.5 to C.sub.18 alicyclic hydrocarbon group that may have a substituent, and * represents a binding site.

Provided herein are methods and intermediates for making (1R,2R,5R)-5-amino-2-methylcyclohexanol hydrochloride, which are useful for the preparation of compounds useful for the treatment of a disease, disorder, or condition associated with the JNK pathway.

Provided herein are methods and intermediates for making (1R,2R,5R)-5-amino-2-methylcyclohexanol hydrochloride, which are useful for the preparation of compounds useful for the treatment of a disease, disorder, or condition associated with the JNK pathway.

Reactive mesogens (RMs), mixtures and formulations comprising RMs, polymers obtained from such RMs and RM mixtures, and the use of the RMs, RM mixtures and polymers in optical or electrooptical components or devices, like optical films for liquid crystal displays (LCDs).

Reactive mesogens (RMs), mixtures and formulations comprising RMs, polymers obtained from such RMs and RM mixtures, and the use of the RMs, RM mixtures and polymers in optical or electrooptical components or devices, like optical films for liquid crystal displays (LCDs).

Disclosed is a mixture containing polymerizable compounds having Formulas (III) and (IV) wherein Ar.sup.1 and Ar.sup.2 are divalent aromatic hydrocarbon or heteroaromatic ring group having D1 or D2 as a substituent; D.sup.1 and D.sup.2 are C1-C20 organic group having at least one aromatic ring selected from the group consisting of aromatic hydrocarbon ring and heteroaromatic ring; A.sup.11-A.sup.22 and B.sup.11-B.sup.22 are alicyclic or aromatic group which may have a substituent, Y.sup.11-Y.sup.22 and L.sup.11-L.sup.22 are single bond, —O—, —CO—, —CO—O—, —O—CO—, —NR.sup.21—CO—, —CO—NR.sup.22—, —O—CO—O—, —NR.sup.23—CO—O—, —O—CO—NR.sup.24— or —NR.sup.25—CO—NR.sup.26— where R.sup.21—R.sup.26 are hydrogen or C1-C6 alkyl group; R.sup.4—R.sup.9 are hydrogen, methyl group or chlorine; one of f and k is integer of 1 to 3 with the other being integer of 0 to 3; g, j, m and q are integer of 1 to 20; and h, i, n and p are 0 or 1. ##STR00001##